Rep. Spanberger Leads Bipartisan 181-Member Effort Pressing Administration to Prevent Damaging Prescription Drug Price Hikes, Preserve Discounts for Virginia's Hospitals & Rural Healthcare Providers
July 19, 2022
July 19, 2022
WASHINGTON, July 19 -- Rep. Abigail Spanberger, D-Virginia, issued the following news release and letter on July 18, 2022:
U.S. Representative Abigail Spanberger led a bipartisan effort with 180 of her colleagues in pressing the Biden Administration to prevent reckless prescription drug cost hikes and defend the 340B Drug Pricing Program in the face of illegal actions from several pharmaceutical companies.
The 340B Drug Pricing Program requires that pharmaceutical compa . . .
U.S. Representative Abigail Spanberger led a bipartisan effort with 180 of her colleagues in pressing the Biden Administration to prevent reckless prescription drug cost hikes and defend the 340B Drug Pricing Program in the face of illegal actions from several pharmaceutical companies.
The 340B Drug Pricing Program requires that pharmaceutical compa . . .